270 related articles for article (PubMed ID: 8458108)
1. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
Shammas NW; Zeitler R; Fitzpatrick P
Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
[TBL] [Abstract][Full Text] [Related]
2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
3. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
Barbagelata NA; Granger CB; Oqueli E; Suárez LD; Borruel M; Topol EJ; Califf RM
Am Heart J; 1997 Mar; 133(3):273-82. PubMed ID: 9060794
[TBL] [Abstract][Full Text] [Related]
4. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
5. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
[TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy in acute myocardial infarction.
Rutherford JD; Braunwald E
Chest; 1990 Apr; 97(4 Suppl):136S-145S. PubMed ID: 2108851
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1.
O'Connor CM; Meese R; Carney R; Smith J; Conn E; Burks J; Hartman C; Roark S; Shadoff N; Heard M
J Am Coll Cardiol; 1994 Jan; 23(1):11-8. PubMed ID: 8277068
[TBL] [Abstract][Full Text] [Related]
9. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
10. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321
[TBL] [Abstract][Full Text] [Related]
11. Current issues concerning thrombolytic therapy for acute myocardial infarction.
Hennekens CH; O'Donnell CJ; Ridker PM; Marder VJ
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):18S-22S. PubMed ID: 7775709
[TBL] [Abstract][Full Text] [Related]
12. Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
Held PH; Teo KK; Yusuf S
Circulation; 1990 Nov; 82(5):1668-74. PubMed ID: 2146038
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic, antiplatelet, and antithrombotic agents.
Grines CL
Am J Cardiol; 1992 Dec; 70(21):18I-26I. PubMed ID: 1471601
[TBL] [Abstract][Full Text] [Related]
14. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS).
Neuhaus KL; von Essen R; Tebbe U; Vogt A; Roth M; Riess M; Niederer W; Forycki F; Wirtzfeld A; Maeurer W
J Am Coll Cardiol; 1992 Apr; 19(5):885-91. PubMed ID: 1552106
[TBL] [Abstract][Full Text] [Related]
15. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
16. [Thrombolytic drugs in acute myocardial infarct].
Ambrosioni E; Degli Esposti D
Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
18. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
Baxter-Jones CS; White HD; Anderson JL
J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637
[TBL] [Abstract][Full Text] [Related]
19. Survival following thrombolytic therapy.
Sleight P
Eur Heart J; 1990 Aug; 11 Suppl F():1-4. PubMed ID: 2121486
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.
Bassand JP; Cassagnes J; Machecourt J; Lusson JR; Anguenot T; Wolf JE; Maublant J; Bertrand B; Schiele F
Circulation; 1991 Sep; 84(3):1107-17. PubMed ID: 1909218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
